0001227835-15-000001.txt : 20151116
0001227835-15-000001.hdr.sgml : 20151116
20151116205558
ACCESSION NUMBER: 0001227835-15-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151113
FILED AS OF DATE: 20151116
DATE AS OF CHANGE: 20151116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SARGEN GREGORY
CENTRAL INDEX KEY: 0001227835
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 151236870
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-11-13
0000820081
CAMBREX CORP
CBM
0001227835
SARGEN GREGORY
1 MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
0
1
0
0
Executive Vice President & CFO
Common Stock
2015-11-13
4
M
0
6250
5.72
A
39569
D
Common Stock
2015-11-13
4
M
0
7500
12.46
A
47069
D
Common Stock
2015-11-13
4
M
0
7500
16.905
A
54569
D
Common Stock
2015-11-13
4
M
0
7500
17.81
A
62069
D
Common Stock
2015-11-13
4
S
0
28750
49.14
D
33319
D
Stock Option (right to buy)
5.72
2015-11-13
4
M
0
6250
0
A
2018-10-18
Common Stock
6250
0
D
Stock Option (right to buy)
12.46
2015-11-13
4
M
0
7500
0
A
2019-10-24
Common Stock
7500
7500
D
Stock Option (right to buy)
16.905
2015-11-13
4
M
0
7500
0
A
2020-10-28
Common Stock
7500
15000
D
Stock Option (right to buy)
17.81
2015-11-13
4
M
0
7500
0
A
2021-10-22
Common Stock
7500
22500
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.455 inclusive. The reporting person untertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 18, 2012, which was the first anniversary of the date on which the option was granted.
The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 24, 2013 which was the first anniversary of the date on which the option was granted.
The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted.
The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.
Samantha Hanley for Gregory P. Sargen by POA
2015-11-16